Hereditary Prostate Cancer Risk:

Hereditary prostate cancer risk is real. In this context, hereditary means the risk is linked to an inherited gene change that can be passed down through a family. For men with the right family history pattern, genetic testing can help identify whether one of these inherited changes is present. That information can shape how risk is assessed and managed, often before any symptoms appear.
‍

This article explains which family history indicators suggest increased inherited prostate cancer risk, who the authorities recommend for testing, what the testing process looks like, and what a positive result means for your screening plan.

How Your Family History Affects Your Prostate Cancer Risk

Your Situation	What It Means for You	What to Do
No family history of prostate cancer	Your risk is similar to that of the general population: about 1 in 7 men will develop prostate cancer in their lifetime.	Follow standard screening guidance, typically starting PSA discussions with your physician around age 50.
Your father or brother had prostate cancer	Your risk is roughly double that of men with no family history.	Talk to your physician about starting PSA screening earlier, around age 45.
Your father or brother was diagnosed before age 55	An earlier diagnosis in a close relative is a stronger signal; it suggests a hereditary pattern rather than a typical age-related cancer.	Your physician may recommend starting PSA monitoring at age 40 to 45 and testing more frequently.
Two or more close male relatives had prostate cancer	Your risk may be 5 to 11 times higher than that of a man with no family history. This is a significant signal.	Genetic testing is strongly recommended to find out whether an inherited mutation is driving that pattern.
You carry a BRCA2 mutation from either parent	Your prostate cancer risk is 2 to 6 times elevated, and any cancer that develops may be more aggressive	Annual PSA testing starting at age 40, genetic counseling, and a physician familiar with hereditary prostate cancer.

Which Family History Indicators Suggest Inherited Prostate Cancer Risk?

Inherited prostate cancer risk is most commonly identified through family history. Genetic testing is the only way to confirm whether a harmful gene mutation is present, but certain family history patterns make it significantly more likely.

How Your Family History Raises Your Risk

A man's prostate cancer risk rises substantially with each first-degree relative, meaning a father or brother, who has been diagnosed with the disease. (American Cancer Society)

One first-degree relative with prostate cancer: Your risk is approximately double that of men with no family history.
Two or more first-degree relatives with prostate cancer: Your risk may be 5 to 11 times higher than average.
A first-degree relative diagnosed before age 55: An early diagnosis in a close relative suggests an increased inherited risk rather than a typical age-related cancer.

The more relatives affected and the younger their ages at diagnosis, the stronger the indication that an inherited harmful gene mutation may be driving the family pattern.

When the Risk Comes From Female Relatives

Many men only think about their father's or brother's prostate cancer history. But inherited prostate cancer risk can come from either side of the family, including through female relatives:

A female relative with a BRCA2 mutation, whether a mother, sister, or daughter, is a clear indicator that her male relatives may also carry the mutation. A man who inherits a BRCA2 mutation faces 2 to 6 times elevated prostate cancer risk, and prostate cancers in BRCA2 carriers tend to be more aggressive.
A family history that includes breast cancer, ovarian cancer, or pancreatic cancer alongside prostate cancer may suggest an inherited BRCA-related cancer pattern, making genetic testing clinically relevant for male relatives.
Lynch syndrome, identified through a family history of colorectal or endometrial cancer, also moderately elevates prostate cancer risk in male carriers. (CDC Genomics)

If any of these patterns appear in your family, they may be relevant to your risk regardless of whether they came through your mother's or father's side.

Who Should Consider Genetic Testing for Inherited Prostate Cancer Risk?

The NCI, Prostate Cancer Genetics evidence summary has established specific criteria for hereditary prostate cancer genetic testing.
‍

Men meeting any of the following criteria should discuss testing with their physician:

A personal history of prostate cancer with a Gleason score of 7 or higher, which describes how aggressive the cancer appears under a microscope, and a first-degree relative with prostate cancer before age 60
A personal history of prostate cancer with two or more relatives with prostate cancer on the same side of the family
A first-degree relative with a confirmed BRCA1, BRCA2, or Lynch syndrome gene mutation
A family history of ovarian cancer, breast cancer before 50, or pancreatic cancer combined with prostate cancer, suggesting a BRCA carrier family
Ashkenazi Jewish ancestry combined with any personal or family cancer history

Proactive Testing Before a Diagnosis

Genetic testing for inherited prostate cancer risk is not only for men who have already been diagnosed. Many men with concerning family history patterns pursue testing proactively, before any symptoms or abnormal PSA results appear.

This matters because results directly shape surveillance decisions. A man who knows he carries a harmful BRCA2 gene mutation may start PSA screening earlier and undergo more frequent monitoring, often beginning around age 40 rather than age 50, with guidance from a physician who understands what that result means for his situation.

‍

See how your genes affect your inherited prostate cancer risk.

Kadance members receive access to hereditary cancer risk testing covering 26 genes, including BRCA1, BRCA2, and key genes associated with Lynch syndrome, plus genetic counseling to help interpret positive results and plan next steps.

What Does a Hereditary Prostate Cancer Risk Genetic Panel Test For?

A comprehensive hereditary cancer panel for prostate cancer risk analyzes multiple genes simultaneously from a single cheek swab, saliva sample, or blood draw. Genes typically included are:

BRCA1 and BRCA2: The most significant hereditary prostate cancer risk genes. Both are inherited equally from either parent and are also associated with breast, ovarian, and pancreatic cancer risk.
Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2): Associated with moderate prostate cancer risk elevation, alongside their primary colorectal and endometrial cancer associations.
HOXB13: A prostate-specific gene. A particular variant called G84E is associated with early-onset hereditary prostate cancer.
ATM, PALB2, CHEK2: Additional genes with growing evidence for prostate cancer association.

Results are typically returned within 2 to 4 weeks and interpreted by a genetic counselor in the context of your personal and family history.

When Should Men with Increased Hereditary Risk Start Prostate Cancer Screening?

For most men, doctors recommend starting conversations about prostate cancer screening around age 50. But that guideline is designed for average-risk men. If you have a confirmed inherited harmful gene mutation or a strong family history, the standard starting age may be too late.
‍

PSA screening is a simple blood test that measures a protein produced by the prostate. Higher-than-expected levels may indicate the need for further evaluation. For men with increased hereditary risk, starting PSA screening earlier and repeating it more often can improve the chance of detecting prostate cancer earlier.

Here is what the current guidelines recommend based on your specific risk level:
‍

Confirmed BRCA2 carriers: Begin annual PSA testing at age 40, in shared decision-making with a urologist.
Confirmed BRCA1 carriers: Begin discussions about screening at age 40 to 45, with an individualized approach.
Lynch syndrome carriers: Include prostate cancer surveillance as part of the broader Lynch syndrome monitoring plan, per physician guidance.
Men with a strong family history but no confirmed harmful mutation: discuss PSA testing beginning at age 40-45, per NCCN recommendations, with individual risk assessment.(NCI, Prostate Cancer Genetics)

Earlier surveillance matters because prostate cancer in men with increased inherited risk tends to be more aggressive, making early detection especially important compared with men at average risk.

What Happens After a Positive Genetic Test Result?

A positive result, meaning a harmful inherited gene mutation was identified, opens a set of clinical conversations that are simply not available to men who do not know their status.
‍

Steps after a positive result, managed in partnership with a physician, typically include:

Earlier PSA monitoring: Starting at the age recommended for the specific gene involved, as described above.
Specialist referral: A urologist with experience in hereditary cancer can provide more tailored surveillance than standard urology care, which is not always designed for hereditary risk management.
Multiparametric MRI: May be integrated into surveillance planning for BRCA2 carriers, depending on PSA results over time.
Family communication: All first-degree relatives, brothers, sons, sisters, and daughters each have a 50% chance of carrying the same gene change. A genetic counselor helps you navigate how and when to share this with family members who may want to consider testing.
Monitoring for associated cancers: BRCA2 carriers also face elevated breast and pancreatic cancer risk. Lynch syndrome carriers face elevated colorectal and other cancer risks. A positive result triggers a broader cancer risk management conversation, not just a prostate cancer plan.

FAQ: Inherited Prostate Cancer Risk Testing

Can genetic testing predict if I will get prostate cancer?

No. Genetic testing identifies whether you carry a gene mutation that elevates your lifetime risk of prostate cancer. It cannot predict whether or when cancer will develop. Many men with hereditary prostate cancer gene mutations live their full lives without a diagnosis. The value of knowing is that it enables you to pursue proactive surveillance and risk-management decisions calibrated to your actual biological risk, rather than population-average assumptions.

Should I get tested if only one family member had prostate cancer?

It depends on the circumstances. One first-degree relative with prostate cancer doubles the average risk, but does not necessarily indicate an inherited harmful gene mutation. However, if that relative was diagnosed before age 55, if other cancers also appear in the family, such as breast, ovarian, pancreatic, or colorectal cancer, or if you have Ashkenazi Jewish ancestry, testing may be clinically appropriate. A genetic counselor can review your complete family history and advise whether testing makes sense for your situation.

How is genetic testing for prostate cancer risk different from a PSA test?

PSA testing measures a protein in the blood to detect current signs of prostate cancer or prostate inflammation. It is a screening tool used repeatedly throughout a man's life. Genetic testing analyzes the DNA you were born with to find inherited gene mutations that increase your lifetime cancer risk. It is done once, and the results are relevant for life. Genetic testing informs when PSA monitoring should begin and how intensively it should be conducted. The two tools work together, not as alternatives.

Inherited Prostate Cancer Risk: The Right Time to Find Out Is Before You Need To

If prostate cancer runs in your family, the most valuable time to understand inherited risk is before cancer is ever diagnosed. Genetic testing can clarify whether an inherited gene change is part of the picture and what that may mean for screening and next steps.
‍

Kadance exists to make that knowledge accessible. Members receive hereditary cancer risk testing across 26 clinically actionable genes, genetic counseling to interpret results, and a documented plan their physician can act on. The best time to find out is now, while you still have the most options.

‍

Be proactive about your health.

Know your inherited cancer risk before a diagnosis changes the conversation. Explore Kadance membership for access to hereditary cancer risk testing, genetic counseling, and proactive precision health support.

‍

The information in this article is intended for educational purposes only and does not constitute medical advice. It may not fully reflect the current scope of Kadance services, testing panels, or program offerings. For the most accurate and up-to-date information about what Kadance includes, please visit kadance.com or speak with a member of our team.

‍